Gubra A/S engages in providing research and development services to pharmaceutical and biotechnology companies on a contract basis. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.
Follow-Up Questions
GUBRF の株価パフォーマンスは？
GUBRF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Gubra A/S の主な事業テーマや業界は？
Gubra A/S は Life Sciences Tools & Services 業界、セクターは Health Care に属しています。
